The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47.
Range Resources Corporation
RRC · the NYSE · USD · Market cap $12.1B · 564 employees
Range Resources Corporation operates as an independent natural gas, natural gas liquids (NGLs), and oil company in the United States.
PASS · Titan Ethical · score 64.7Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price48.45 USD at the 19 Nov 2026 close
- Our value readFair vs our fair value, as of 19 Nov 2026
- Our regime readMarkup, as of 17 Nov 2026
- Ethical screenPasses, score 64.7 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.25)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $37.80 to $51.09, base estimate $44.43 (screen dated 2026-11-19).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.25, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Range Resources Corporation holds its Markup at $48.45. Consolidating, no directional conviction, held for 18 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 18 days |
| Price at the screen | $48.45 |
| Valuation | 13.75 trailing · 12.57 forward price to earnings |
| Values screen | PASS · score 64.7 |
| Beta | 0.62 |
Five Screens: RRC's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 18.49% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 4.84% | Below 49% | Pass |
| Revenue purity | 0.16% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
Range Resources clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when RRC's ethical verdict changes
Today RRC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades above our $44.43 fair value estimate, 19.70% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 9.0% above the base estimate.
Third-party analyst targets: 19 covering, consensus Hold. The average target sits +11% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $44.43, with a range of $37.80 to $51.09, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsAppalachian gas wells hide a classic cyclical trap
Every winter price spike or LNG export boom sends more cash through Range Resources Appalachian wells. The numbers look solid with revenue up 26 percent, a 28 percent profit margin and 21 percent return on equity, all at a forward multiple of just 8.6 times. Current price sits 9 percent below our fair value estimate, yet the opportunity rating remains none.
This is the textbook cyclical value trap. Low multiples in energy often signal peak earnings rather than bargains, and the market is correctly treating the cycle as temporary. Twenty two analysts hold a neutral stance with a 44 dollar median target that already prices in some recovery.
Commodity swings and exploration risks sit at the heart of the downside. The ethical screen clears the business, but the cycle itself keeps any real edge out of reach. Analysis, not advice.
| Forward P/E | 12.6xcheap for a company growing this fast |
| Trailing P/E | 13.7xreasonably valued |
| EPS, trailing | 3.77 |
| EPS, forward | 4.12 |
| Revenue growth | +19.7%steady growth |
| Profit margin | 26.2%healthy profit margins |
| Return on equity | 19.6%a solid return on shareholder capital |
| FCF yield | 3.39% |
| Dividend yield | 1.01% |
| Debt to equity | 0.19minimal debt: a conservative balance sheet |
| Current ratio | 0.74below 1: short-term bills exceed liquid assets |
| Beta | 0.62steadier than the market |
| Short interest, float | 0.09% |
| 52-week range | 32.68 - 56.90 |
| Market cap | $12.1B |
| Employees | 564 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 10.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 26.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 14% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 14% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 14% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Here is Why Range Resources (RRC) Could be Vulnerable to a Sharp Correction Yahoo Finance · 6d ago
- Midterms Send Energy Packing, But These Sectors Gain In IBD 50 Yahoo Finance · 14d ago
- ConocoPhillips Q3 Earnings Beat Estimates on Higher Commodity Prices Yahoo Finance · 14d ago
- Why Is Everyone Ignoring Expand Energy Stock's High Cash Yield? Yahoo Finance · 14d ago
- 1 surging stock to research further and 2 we find risky Yahoo Finance · 17d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-05-05 | Brian Babin | Republican | Sale | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $40.97 | -4.5% | · | $955 | -4.5% |
| 2 months | $42.84 | -8.7% | · | $913 | -8.7% |
| 3 months | $42.78 | -8.5% | $0.10 | $917 | -8.3% |
| 6 months | $36.14 | +8.3% | $0.19 | $1,088 | +8.8% |
| 1 year | $38.36 | +2.0% | $0.37 | $1,030 | +3.0% |
| 2 years | $36.74 | +6.5% | $0.70 | $1,084 | +8.4% |
| 3 years | $27.64 | +41.6% | $1.02 | $1,453 | +45.3% |
| 5 years | $15.41 | +153.9% | $1.26 | $2,620 | +162.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever RRC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.